No connection

Search Results

CINT

BULLISH
$4.23 Live
CI&T Inc. · NYSE
Target $7.47 (+76.7%)
$3.98 52W Range $7.09

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$546.08M
P/E
14.1
ROE
13.8%
Profit margin
8.3%
Debt/Equity
0.43
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
75%
CINT presents a classic deep-value opportunity characterized by a stable Piotroski F-Score of 4/9 and a current price ($4.23) trading very close to its Graham Number ($4.02) and significantly below its intrinsic value ($8.85). While technical trends are severely bearish (0/100) and long-term price performance is poor, the fundamental growth metrics are exceptional, with YoY earnings growth of 36.8% and a low forward P/E of 8.66. The divergence between the 'Strong Buy' analyst consensus and the current price collapse suggests a significant market mispricing of the company's growth trajectory.

Key Strengths

Strong earnings growth (YoY +36.8%, Q/Q +94.6%)
Attractive valuation with a forward P/E of 8.66
Trading near defensive fair value (Graham Number $4.02)
Healthy balance sheet with low Debt/Equity (0.43)
Strong analyst conviction with a target price of $7.47

Key Risks

Severe technical breakdown (0/100 trend score)
Poor long-term price performance (5Y change -76.7%)
Low insider sentiment (40/100)
Lack of dividend yield for income support
Market momentum is heavily bearish despite fundamental strength
AI Fair Value Estimate
Based on comprehensive analysis
$6.44
+52.2% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
50
Moderate
Value
90
Future
85
Past
20
Health
55
Dividend
0
AI Verdict
Fundamental Value Play
Key drivers: Earnings growth, Low P/E ratio, Intrinsic value gap, Technical collapse
Confidence
80%
Value
90/100

P/E 14.10, Graham Number $4.02, Intrinsic Value $8.85

Positives
  • Price is near Graham Number
  • Significant discount to Intrinsic Value
  • Low Forward P/E
Watchpoints
  • Price/Book is slightly elevated at 1.76
Future
85/100

Ref Growth rates and Analyst Target $7.47

Positives
  • High YoY Revenue Growth (19.3%)
  • Accelerating Earnings Growth (36.8%)
  • Strong Q/Q EPS surprise history
Watchpoints
  • Market is not currently pricing in this growth
Past
20/100

Ref Historical price trends

Positives
  • Recent quarterly beats
Watchpoints
  • Devastating 5Y return (-76.7%)
  • Consistent 1Y decline (-20.3%)
Health
55/100

Ref Piotroski F-Score 4/9

Positives
  • Low Debt/Equity (0.43)
  • Stable Current Ratio (1.33)
Watchpoints
  • Piotroski F-Score is only 4/9 (Stable, not Strong)
Dividend
0/100

Ref Dividend Yield N/A

Positives
No standout positives identified.
Watchpoints
  • No dividend payments
  • 0% payout ratio

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$4.23
Analyst Target
$7.47
Upside/Downside
+76.7%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CINT and closest competitors.

Updated 2026-04-24
CIN
CI&T Inc.
Primary
5Y
-76.7%
3Y
+5.8%
1Y
-20.3%
6M
-14.7%
1M
-12.6%
1W
-10.8%
MLA
Mesa Laboratories, Inc.
Peer
5Y
-61.0%
3Y
-39.5%
1Y
-13.6%
6M
+43.8%
1M
+25.5%
1W
+3.8%
RDV
Red Violet, Inc.
Peer
5Y
+90.6%
3Y
+145.8%
1Y
+7.3%
6M
-23.2%
1M
-0.5%
1W
+11.0%
AMB
Ambiq Micro, Inc.
Peer
5Y
-34.2%
3Y
-34.2%
1Y
-34.2%
6M
-26.4%
1M
-13.5%
1W
-10.7%
GLO
Gloo Holdings, Inc.
Peer
5Y
-22.2%
3Y
-22.2%
1Y
-22.2%
6M
-22.2%
1M
+3.5%
1W
+10.7%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
14.1
Forward P/E
8.66
PEG Ratio
N/A
P/B Ratio
1.76
P/S Ratio
1.12
EV/Revenue
1.28
EV/EBITDA
8.19
Market Cap
$546.08M

Profitability

Profit margins and return metrics

Profit Margin 8.3%
Operating Margin 13.65%
Gross Margin 31.97%
ROE 13.79%
ROA 7.61%

Growth

Revenue and earnings growth rates

Revenue Growth +19.3%
Earnings Growth +36.8%
Q/Q Revenue Growth +8.15%
Q/Q Earnings Growth +38.6%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.43
Low debt
Current Ratio
1.33
Good
Quick Ratio
1.29
Good
Cash/Share
$0.37

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.1B
Gross Margin
32.3%
Op. Margin
12.1%
Net Margin
10.8%
Total Assets
$0.6B
Liabilities
$0.2B
Equity
$0.3B
Debt/Equity
0.78x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
85%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-11
$N/A
2026-03-11
$0.72
+38.8% surprise
2025-11-12
$0.37
-12.0% surprise
2025-08-13
$0.38
+36.1% surprise

Technology Sector Comparison

Comparing CINT against 528 companies in the Technology sector (46 bullish, 175 neutral, 307 bearish)
P/E Ratio
14.1
This Stock
vs
85.73
Sector Avg
-83.6% (Discount)
Return on Equity (ROE)
13.79%
This Stock
vs
-36.43%
Sector Avg
-137.9% (Below Avg)
Profit Margin
8.3%
This Stock
vs
-12.81%
Sector Avg
-164.8% (Weaker)
Debt to Equity
0.43
This Stock
vs
0.71
Sector Avg
-39.7% (Less Debt)
Revenue Growth
19.3%
This Stock
vs
4697.82%
Sector Avg
-99.6% (Slower)
Current Ratio
1.33
This Stock
vs
3.69
Sector Avg
-63.8% (Weaker)

Similar Companies

Peer comparison within the same industry

SEC Filings

Recent regulatory filings from the SEC EDGAR database

20-F
20-F
2026-03-11

CINT filed its annual 20-F report on March 11, 2026. Due to the absence of provided excerpts, specific financial highlights and risk factors cannot be detailed at this time.

20-F
20-F
2025-03-28

CINT filed its annual report on Form 20-F on March 28, 2025. Due to the absence of detailed excerpts, specific financial highlights and risk factors are not available for summary.

Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
10 analysts
UBS
2026-03-12
Maintains
Buy Buy
Canaccord Genuity
2026-03-12
Maintains
Buy Buy
JP Morgan
2026-02-18
Maintains
Overweight Overweight
UBS
2026-01-15
up
Neutral Buy
Canaccord Genuity
2025-11-13
Maintains
Buy Buy
JP Morgan
2025-11-13
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning CINT from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile